ENTITY

Coeptis Therapeutics Holdings (COEP US)

7
Analysis
Health Care • United States
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes.
more
•28 Oct 2022 08:00•Issuer-paid

SPAC Talk: Desperation and Despair

KEY HIGHLIGHTS Do or die! We can confirm that as we approach the end of the month, October will be the best month of 2022 so far in terms of deal...

Logo
685 Views
Share
•21 Aug 2023 21:10•Issuer-paid

Coeptistx (COEP) Deverra Deal Flash Note 21082023

COEP’s exclusive license deal with Deverra for DVX201, two products ’54’ & ‘16’ provides access to Deverra’s no-HLA-matching platform asset.

Logo
370 Views
Share
•29 Jun 2023 20:26•Issuer-paid

Coeptis Therapeutics Inc. (COEP) YE22 1Q23 & DeSPAC 29062023

COEP is a pre-clinical stage bio-pharma corp targeting CD38+ related unmet need and solidtumor cancers.YE22A results show wash through of the SPAC...

Logo
517 Views
Share
•21 Apr 2023 19:41•Issuer-paid

Coeptistx (COEP) Deverra Deal Flash Note 20042023

Coeptis Therapeutics Inc., a pre-clinical stagebiopharmaceutical Corp, announced an exclusive term sheet to acquire or license Deverra...

Logo
539 Views
Share
•16 Nov 2022 20:32•Issuer-paid

Coeptis Therapeutics Inc. (COEP) Initiation Note ACF Equity Research 16112022

Coeptis Therapeutics Inc. (NASDAQ: COEP) is a pre-clinical stage biopharmaceutical Corp focused on fighting cancer via a pipeline of potentially...

Logo
450 Views
Share
x